LONDON, Sept. 30, 2019 /PRNewswire/ -- Building on the topics covered in our March 2019 report, the latest edition of Healthcare & Life Sciences Review Spain takes a closer look at the broader Spanish life sciences value chain.
With the Iberian nation enjoying an economic rebound, pharmaceutical multinationals are once again seeing Spain as a favourable investment
This trend is also prevalent in the medical devices sphere, with Becton Dickinson and B Braun, to name but two, looking once more to Spain.
Medtech firms are also at the forefront of another key trend tackled in this report: Spain's move towards a value-based healthcare model and how public and private actors are interacting to create innovative and digital solutions.
Other topics touched on in this comprehensive and wide-ranging report include how the region of Catalonia is forging ahead in healthcare innovation, why Spain is increasingly a happy hunting ground for resourceful generics firms, and how players in niches as diverse as dermo-cosmetics and bugtech are achieving Spanish success.
Download the report here
View original content:http://www.prnewswire.com/news-releases/pharmaboardroom-releases-healthcare--life-sciences-review-spain-september-2019-pharma-report-300927749.html
Subscribe to our Free Newsletters!